S3V Vascular Technologies
PrivateLast Round
Series B
Mar 14, 2024
Total Funding Raised
$43.52M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
S3V Vascular Technologies operates in Healthcare & Life Sciences and is based in Mysuru. Its latest recorded funding round was a Series B round in March 2024.
S3V Vascular Technologies is a medical devices company that develops, manufactures, and markets minimally invasive cardiovascular, neurovascular, and critical-care medical devices.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
S3V Vascular Technologies Comparables
Compare S3V Vascular Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Relisys Medical Devices | 86% | |
| Translumina Therapeutics | 84% | |
| Innvolution Healthcare Private Limited | 84% |
For institutional investors. Book with your work email.
S3V Vascular Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 14, 2024 | ||||
| Series A | Jul 1, 2022 | ||||
| Debt | May 9, 2017 | ||||
| Seed | Aug 9, 2011 |
For institutional investors. Book with your work email.
S3V Vascular Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jain International Trade Organisation | Series A |
| Technology Development Board | Debt, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 16, 13% of headcount.
- Jul 13, 2026
Open roles increased to 16, 5.3x the trailing average.
For institutional investors. Book with your work email.
S3V Vascular Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about S3V Vascular Technologies's valuation, stock price, and market status.
Is S3V Vascular Technologies a public or private company?
S3V Vascular Technologies is a private company.
What is the current stock price of S3V Vascular Technologies?
S3V Vascular Technologies is a private company, so its shares have no public market price. Caplight tracks S3V Vascular Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is S3V Vascular Technologies worth (valuation)?
Valuation information for S3V Vascular Technologies is not publicly available.
Can I buy S3V Vascular Technologies stock?
S3V Vascular Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was S3V Vascular Technologies's last funding round?
S3V Vascular Technologies's most recent funding round was Series B on March 14, 2024.
Who are the main investors in S3V Vascular Technologies?
Key investors in S3V Vascular Technologies include Jain International Trade Organisation, Technology Development Board.
Will S3V Vascular Technologies IPO soon?
No public IPO plans have been announced for S3V Vascular Technologies.
How can I track S3V Vascular Technologies secondary market activity?
Caplight tracks bids, offers, and trades in S3V Vascular Technologies's shares on secondary markets.